Evidence map›Paper›PMID 32425981›Full record

ArticleFrontiers in genetics2020

Direct RNA Sequencing for the Study of Synthesis, Processing, and Degradation of Modified Transcripts.

Mattia Furlan, Iris Tanaka, Tommaso Leonardi, Stefano de Pretis, Mattia Pelizzola

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Mapping the future of oxidative RNA damage in neurodegeneration: Rethinking the status quo with new tools.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Long Non-Coding RNA Epigenetics.International journal of molecular sciences · 2021
    Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mattia FurlanCenter for Genomic Science, Istituto Italiano di Tecnologia, Milan, Italy.
Iris TanakaCenter for Genomic Science, Istituto Italiano di Tecnologia, Milan, Italy.
Tommaso LeonardiCenter for Genomic Science, Istituto Italiano di Tecnologia, Milan, Italy.
Stefano de PretisCenter for Genomic Science, Istituto Italiano di Tecnologia, Milan, Italy.
Mattia PelizzolaCenter for Genomic Science, Istituto Italiano di Tecnologia, Milan, Italy.
Center for Genomic Science · ITItalian Institute of Technology · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been known for a few decades that transcripts can be marked by dozens of different modifications. Yet, we are just at the beginning of charting these marks and understanding their functional impact. High-quality methods were developed for the profiling of some of these marks, and approaches to finely study their impact on specific phases of the RNA life-cycle are available, including RNA metabolic labeling. Thanks to these improvements, the most abundant marks, including N

Indexed as

direct RNA sequencinglong reads sequencingm6Ametabolic labelingnanoporenascent RNARNA metabolismRNA modification

Identifiers

PMID32425981
PMCPMC7212349
OpenAlexW3022558834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.